S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY

Detalles Bibliográficos
Autores principales: Bal, Susan, Berdeja, Jesus, Htut, Myo, Kocoglu, Mehmet, Gregory, Tara, Anderson, Larry D., Rossi, Adriana, Egan, Daniel, Costa, Luciano, Kelly, Lisa, Ziyad, Safiyyah, Hu, Hongxiang, Chen, Yanping, Kaeding, Allison J., Burgess, Michael, Hege, Kristen, Nadeem, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428438/
http://dx.doi.org/10.1097/01.HS9.0000967684.98632.87
_version_ 1785090469269602304
author Bal, Susan
Berdeja, Jesus
Htut, Myo
Kocoglu, Mehmet
Gregory, Tara
Anderson, Larry D.
Rossi, Adriana
Egan, Daniel
Costa, Luciano
Kelly, Lisa
Ziyad, Safiyyah
Hu, Hongxiang
Chen, Yanping
Kaeding, Allison J.
Burgess, Michael
Hege, Kristen
Nadeem, Omar
author_facet Bal, Susan
Berdeja, Jesus
Htut, Myo
Kocoglu, Mehmet
Gregory, Tara
Anderson, Larry D.
Rossi, Adriana
Egan, Daniel
Costa, Luciano
Kelly, Lisa
Ziyad, Safiyyah
Hu, Hongxiang
Chen, Yanping
Kaeding, Allison J.
Burgess, Michael
Hege, Kristen
Nadeem, Omar
author_sort Bal, Susan
collection PubMed
description
format Online
Article
Text
id pubmed-10428438
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284382023-08-17 S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY Bal, Susan Berdeja, Jesus Htut, Myo Kocoglu, Mehmet Gregory, Tara Anderson, Larry D. Rossi, Adriana Egan, Daniel Costa, Luciano Kelly, Lisa Ziyad, Safiyyah Hu, Hongxiang Chen, Yanping Kaeding, Allison J. Burgess, Michael Hege, Kristen Nadeem, Omar Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428438/ http://dx.doi.org/10.1097/01.HS9.0000967684.98632.87 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Bal, Susan
Berdeja, Jesus
Htut, Myo
Kocoglu, Mehmet
Gregory, Tara
Anderson, Larry D.
Rossi, Adriana
Egan, Daniel
Costa, Luciano
Kelly, Lisa
Ziyad, Safiyyah
Hu, Hongxiang
Chen, Yanping
Kaeding, Allison J.
Burgess, Michael
Hege, Kristen
Nadeem, Omar
S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY
title S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY
title_full S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY
title_fullStr S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY
title_full_unstemmed S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY
title_short S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1 STUDY
title_sort s193: bms-986393 (cc-95266), a g protein–coupled receptor class c group 5 member d (gprc5d)–targeted car t-cell therapy for relapsed/refractory multiple myeloma (rrmm): results from a phase 1 study
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428438/
http://dx.doi.org/10.1097/01.HS9.0000967684.98632.87
work_keys_str_mv AT balsusan s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT berdejajesus s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT htutmyo s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT kocoglumehmet s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT gregorytara s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT andersonlarryd s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT rossiadriana s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT egandaniel s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT costaluciano s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT kellylisa s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT ziyadsafiyyah s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT huhongxiang s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT chenyanping s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT kaedingallisonj s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT burgessmichael s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT hegekristen s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study
AT nadeemomar s193bms986393cc95266agproteincoupledreceptorclasscgroup5memberdgprc5dtargetedcartcelltherapyforrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1study

Ejemplares similares